Saturday, September 13, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Playtika Shares Under Pressure as Analyst Sentiment Sours

Dieter Jaworski by Dieter Jaworski
September 13, 2025
in Analysis, Gaming & Metaverse, Tech & Software
0
Playtika Holding Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

The investment case for mobile gaming specialist Playtika Holding is facing significant headwinds. Once celebrated as a high-growth contender, the company is now confronting a wave of downward revisions from market analysts. The latest blow comes from UBS, whose recent adjustment sends a powerful message about the stock’s dimming prospects.

A Drastic Forecast Reduction

While maintaining its “Neutral” rating on Playtika, UBS delivered a substantial cut to its price target. The investment bank slashed its projection by a notable 27%, moving from $5.50 to just $4.00 per share. This significant downgrade stems directly from the company’s disappointing quarterly performance reported in August. Although Playtika did manage to grow revenue by 11% year-over-year, this positive development was completely overshadowed by a dramatic collapse in profitability. The company’s adjusted net income plummeted by a staggering 91%, while its GAAP net profit still fell by a concerning 62%.

Guidance Cut and Acquisition Concerns

The earnings report revealed particularly troubling figures on a per-share basis. Playtika achieved a mere $0.02 per share, falling drastically short of the $0.15 analysts had anticipated. In response to these challenges, management promptly revised its full-year revenue guidance downward by approximately 3.5%. One potential bright spot exists in the company’s Direct-to-Consumer (DTC) initiative, which is showing promising results and is expected to represent 40% of business long-term, up from its current 25% contribution.

Should investors sell immediately? Or is it worth buying Playtika Holding?

Further complicating the outlook is Playtika’s substantial acquisition of SuperPlay. The mobile developer was purchased in November 2024 for $700 million, with potential performance-based add-ons reaching up to $1.25 billion. This strategic bet has yet to deliver meaningful returns and continues to weigh on the company’s balance sheet.

Looking Ahead to Q3 Results

With shares trading near their 52-week low, investor attention is now firmly fixed on the upcoming Q3 results, scheduled for early November. The critical question remains whether Playtika can demonstrate improved cost control and continue advancing its DTC strategy effectively. The current wave of analyst skepticism suggests that the company faces an uphill battle to restore market confidence and avoid further setbacks.

Ad

Playtika Holding Stock: Buy or Sell?! New Playtika Holding Analysis from September 13 delivers the answer:

The latest Playtika Holding figures speak for themselves: Urgent action needed for Playtika Holding investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 13.

Playtika Holding: Buy or sell? Read more here...

Tags: Playtika Holding
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Viking Therapeutics Stock
Analysis

Viking Therapeutics Faces Investor Scrutiny Over Weight-Loss Drug Tolerability

September 13, 2025
Orange County Stock
Analysis

Orange County Bancorp: A Tale of Steady Dividends and Mounting Credit Concerns

September 13, 2025
Acacia Research Stock
Analysis

Acacia Research Shares Plummet Despite Record Revenue Growth

September 13, 2025
Next Post
Goldman Sachs BDC Stock

Goldman Sachs BDC: A Dividend Bonanza Amidst Share Price Weakness

Chimera Investment Stock

Chimera Investment's $115 Million Bond Offering: A Strategic Infusion or Temporary Relief?

Amazon Stock

US Regulators Target Amazon's Lucrative Advertising Operations

Recommended

Five Bancorp Stock

Regional Banks Face Fed Policy Crossroads as Five Bancorp Shares Fluctuate

1 week ago
Cheniere Energy Stock

America’s Quiet Energy Giant Powers Global Transition

3 weeks ago
Dow Inc Stock

Dow Secures Major $540 Million Infrastructure Investment Amid Market Challenges

2 weeks ago
AMT stock news

Strategic Acquisition: SG Americas Securities LLC Invests in RxSight, Inc. to Drive Medical Technology Advancements

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alphabet Amazon AMD AMZN Apple BA BigBear.ai BioNTech Broadcom Coinbase DIS Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF MSFT NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir Pepsi Realty Income Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla Tilray TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Institutional Investors Flock to Northeast Bancorp on Strong Quarterly Performance

Landmark Ruling Secures Alphabet’s Core Business Model

MP Materials Shares Face Selling Pressure Despite Robust Financial Results

Aviat Networks Stock Surges on Stellar Earnings and Analyst Upgrade

Turtle Beach Forges PlayStation Alliance with New Gaming Headset

Is Blue Foundry Bancorp a Hidden Gem or a Value Trap?

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics Faces Investor Scrutiny Over Weight-Loss Drug Tolerability

by Robert Sasse
September 13, 2025
0

Investors are reassessing Viking Therapeutics' clinical trial data as concerns emerge about patient discontinuation rates in the...

Orange County Stock

Orange County Bancorp: A Tale of Steady Dividends and Mounting Credit Concerns

September 13, 2025
Acacia Research Stock

Acacia Research Shares Plummet Despite Record Revenue Growth

September 13, 2025
Northeast Bancorp Stock

Institutional Investors Flock to Northeast Bancorp on Strong Quarterly Performance

September 13, 2025
Alphabet Stock

Landmark Ruling Secures Alphabet’s Core Business Model

September 13, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Viking Therapeutics Faces Investor Scrutiny Over Weight-Loss Drug Tolerability September 13, 2025
  • Orange County Bancorp: A Tale of Steady Dividends and Mounting Credit Concerns September 13, 2025
  • Acacia Research Shares Plummet Despite Record Revenue Growth September 13, 2025

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com